Sarepta Partners with StrideBio

November 26, 2019

Sarepta Partners with StrideBio

Sarepta has given StrideBio, a company with expertise in adeno-associated viruses and capsids, a license to research, develop and manufacture up to eight gene therapies. "With our partnership with StrideBio, Sarepta continues to build on its leadership position in gene therapies to treat rare diseases," said Doug Ingram, CEO. Yourway provides services for cell and gene therapy companies, and has the regulatory expertise needed to support these therapies globally.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?